Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. (Q42664102)
Jump to navigation
Jump to search
scientific article published on 20 August 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. |
scientific article published on 20 August 2012 |
Statements
1 reference
Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. (English)
1 reference
1 reference
Emilio Perucca
1 reference
Gregory L Krauss
1 reference
Elinor Ben-Menachem
1 reference
Jerry J Shih
1 reference
David Squillacote
1 reference
Haichen Yang
1 reference
Michelle Gee
1 reference
Jin Zhu
1 reference
Antonio Laurenza
1 reference
20 August 2012
1 reference
1 reference
54
1 reference
1
1 reference
126-134
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference